To the full analysis
Buyback calculator for Helus Pharma
Helus Pharma stock: key metrics
HELPHelus Pharma had an operating margin of 0% and a return on invested capital (ROIC) of −47.7% in fiscal 2026.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2017 | no data | no data | no data |
| 2018 | no data | no data | no data |
| 2019 | no data | no data | no data |
| 2021 | −36.0% | −3,592.0% | −3,729.2% |
| 2022 | 0.0% | −38,053.2% | −40,314.1% |
| 2023 | 0.0% | −20,523.9% | −18,919.2% |
| 2024 | no data | no data | no data |
| 2025 | 0.0% | −30,310.4% | −23,956.0% |
| 2026 | no data | no data | no data |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2017 | −43.4% | −34.3% | −28.7% |
| 2018 | −50.2% | −40.9% | −48.4% |
| 2019 | −25.6% | −15.2% | −24.7% |
| 2021 | −37.4% | −55.3% | −35.0% |
| 2022 | −88.8% | −61.7% | −80.5% |
| 2023 | −98.5% | −65.4% | −88.1% |
| 2024 | −26.7% | −36.6% | −25.9% |
| 2025 | −47.7% | −42.7% | −43.7% |
| 2026 | −63.3% | −47.7% | −58.4% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2026, period end 31 Mar 2026
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 15 Oct 2026)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.